← Evidence map

ReviewLeukemia2009

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia.

A Osterborg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19626051